|
| Arnold B Rabson, MD
 |
Acting Director, CHI, RWJMS
The Cancer Institute of New Jersey (CINJ)
195 Little Albany Street, Room 3559
New Brunswick, NJ 08901
rabsonab@umdnj.edu
|
Publications - Kim KE, Gu C, Thakur S, Vieira E, Lin JC, Rabson AB. Transcriptional regulatory effects of lymphoma-associated NFKB2/lyt10 protooncogenes Oncogene. 2000; 19:1334.
- Suh JS, Payvandi F, Edelstein LC, Amenta PS, Zong WX, G?linas C, Rabson AB Mechanisms of constitutive NF-kappaB activation in human prostate cancer cells. Prostate. 2002; 52:183.
- Nelson DA, Tan TT, Rabson AB, Anderson D, Degenhardt K, White E. Hypoxia and defective apoptosis drive genomic instability and tumorigenesis. Genes and Development. 2004; 18:2095.
- Lin HC, Hickey M, Hsu L, Medina D, Rabson AB. Activation of human T cell leukemia virus type 1 LTR promoter and cellular promoter elements by T cell receptor signaling and HTLV-1 Tax expression. Virology. 2005; 339:1.
- Zhao Y, Ramakrishnan A, Kim KE, Rabson AB. Regulation of Bcl-3 through interaction with the Lck tyrosine kinase Biochem Biophys Res Commun. 2005; 335:865.
- Xiao G, Rabson AB, Young W, Qing G, Qu Z Alternative pathways for NF-?B activation: a double-edged sword in health and disease. Cytokine and Growth Factor Reviews. 2006; 17:281.
Research - HIV, HTLV-1, NF-kB, cancer, lymphomas, transcription, gene expression, oncogenesis.
|
|
